Vitamin D and Glaucoma: A Critical Review of the Literature

Primary open-angle glaucoma is a progressive optic neuropathy which can lead to irreversible blindness if untreated. A number of studies have been published suggesting a correlation between the level of serum vitamin D3 and glaucoma or intraocular pressure (IOP). The latter is known to be a major ri...

Full description

Bibliographic Details
Main Authors: Hana Abouzeid, Caroline Flora Samer
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2020/8071280
id doaj-3bc6978841a447c99323f53927fbd155
record_format Article
spelling doaj-3bc6978841a447c99323f53927fbd1552020-11-30T09:11:28ZengHindawi LimitedJournal of Ophthalmology2090-004X2090-00582020-01-01202010.1155/2020/80712808071280Vitamin D and Glaucoma: A Critical Review of the LiteratureHana Abouzeid0Caroline Flora Samer1Ophthalmology Division, Geneva University Hospitals-HUG, Geneva, SwitzerlandClinical Pharmacology and Toxicology Division, Geneva University Hospitals-HUG, Geneva, SwitzerlandPrimary open-angle glaucoma is a progressive optic neuropathy which can lead to irreversible blindness if untreated. A number of studies have been published suggesting a correlation between the level of serum vitamin D3 and glaucoma or intraocular pressure (IOP). The latter is known to be a major risk factor for glaucoma and is the main target of glaucoma treatment. We give a critical review of the literature, exploring what is known about this matter. While some studies report an inverse association between serum vitamin D3 and IOP, others do not confirm this finding. Similar divergent conclusions came from studies regarding the association between serum vitamin D3 and the presence or severity of glaucoma. The effect of vitamin D3 on IOP decrease has been attributed to both aqueous humor production and trabecular meshwork outflow pathway increase. Vitamin D3 has been shown to play a major role in reducing inflammation, modulating the immune response, and decreasing angiogenesis in the eye and in other organs. It has been suggested that, through its neuroprotective effect, vitamin D3 could be a protective factor for glaucoma and that vitamin D3 deficiency could explain glaucoma occurrence or severity in some patients. Other neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis have been similarly related to vitamin D3 deficiency. 1α,25(OH)2 vitamin D3 (calcitriol) supplementation has been shown to be beneficial for lowering IOP in monkeys. Although the studies highlighted in this review show interesting results, their limitations underscore the need for both population-based studies and larger randomized controlled trial with vitamin D3 supplementation. The specific role of vitamin D3 in the pathology of glaucoma remains to be elucidated, together with the possible therapeutic benefit of vitamin D3 supplementation.http://dx.doi.org/10.1155/2020/8071280
collection DOAJ
language English
format Article
sources DOAJ
author Hana Abouzeid
Caroline Flora Samer
spellingShingle Hana Abouzeid
Caroline Flora Samer
Vitamin D and Glaucoma: A Critical Review of the Literature
Journal of Ophthalmology
author_facet Hana Abouzeid
Caroline Flora Samer
author_sort Hana Abouzeid
title Vitamin D and Glaucoma: A Critical Review of the Literature
title_short Vitamin D and Glaucoma: A Critical Review of the Literature
title_full Vitamin D and Glaucoma: A Critical Review of the Literature
title_fullStr Vitamin D and Glaucoma: A Critical Review of the Literature
title_full_unstemmed Vitamin D and Glaucoma: A Critical Review of the Literature
title_sort vitamin d and glaucoma: a critical review of the literature
publisher Hindawi Limited
series Journal of Ophthalmology
issn 2090-004X
2090-0058
publishDate 2020-01-01
description Primary open-angle glaucoma is a progressive optic neuropathy which can lead to irreversible blindness if untreated. A number of studies have been published suggesting a correlation between the level of serum vitamin D3 and glaucoma or intraocular pressure (IOP). The latter is known to be a major risk factor for glaucoma and is the main target of glaucoma treatment. We give a critical review of the literature, exploring what is known about this matter. While some studies report an inverse association between serum vitamin D3 and IOP, others do not confirm this finding. Similar divergent conclusions came from studies regarding the association between serum vitamin D3 and the presence or severity of glaucoma. The effect of vitamin D3 on IOP decrease has been attributed to both aqueous humor production and trabecular meshwork outflow pathway increase. Vitamin D3 has been shown to play a major role in reducing inflammation, modulating the immune response, and decreasing angiogenesis in the eye and in other organs. It has been suggested that, through its neuroprotective effect, vitamin D3 could be a protective factor for glaucoma and that vitamin D3 deficiency could explain glaucoma occurrence or severity in some patients. Other neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis have been similarly related to vitamin D3 deficiency. 1α,25(OH)2 vitamin D3 (calcitriol) supplementation has been shown to be beneficial for lowering IOP in monkeys. Although the studies highlighted in this review show interesting results, their limitations underscore the need for both population-based studies and larger randomized controlled trial with vitamin D3 supplementation. The specific role of vitamin D3 in the pathology of glaucoma remains to be elucidated, together with the possible therapeutic benefit of vitamin D3 supplementation.
url http://dx.doi.org/10.1155/2020/8071280
work_keys_str_mv AT hanaabouzeid vitamindandglaucomaacriticalreviewoftheliterature
AT carolineflorasamer vitamindandglaucomaacriticalreviewoftheliterature
_version_ 1715027783205257216